Treatment of Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: Primum Non Nocere

References

1. 1.↵
   2. Chapman AB,
   3. Devuyst O,
   4. Eckardt KU, et al

   ; Conference Participants. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2015;88:17–27 doi:10.1038/ki.2015.59 pmid:25786098

   CrossRefPubMed
2. 2.↵
   2. Gieteling EW,
   3. Rinkel GJ

   . Characteristics of intracranial aneurysms and subarachnoid haemorrhage in patients with polycystic kidney disease. J Neurol 2003;250:418–23 doi:10.1007/s00415-003-0997-0 pmid:12700905

   CrossRefPubMed
3. 3.↵
   2. Zuka M,
   3. Onoe T,
   4. Kawano M, et al

   . Sudden death of a young male with previously undiagnosed autosomal dominant polycystic kidney disease (ADPKD). Leg Med (Tokyo) 2011;13:35–38 doi:10.1016/j.legalmed.2010.09.003 pmid:20971027

   CrossRefPubMed
4. 4.↵
   2. Klein JP

   . On the role of screening for intracranial aneurysms in autosomal dominant polycystic kidney disease. AJNR Am J Neuroradiol 2013;34:1560–61 doi:10.3174/ajnr.A3466 pmid:23436055

   FREE Full Text
5. 5.↵
   2. Rozenfeld MN,
   3. Ansari SA,
   4. Mohan P, et al

   . Autosomal dominant polycystic kidney disease and intracranial aneurysms: is there an increased risk of treatment? AJNR Am J Neuroradiol 2015 Sep 3. [Epub ahead of print] doi:10.3174/ajnr.A4490 pmid:26338918

   CrossRefPubMed
6. 6.↵
   2. Rahbari-Oskoui F,
   3. Williams O,
   4. Chapman A

   . Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2014;29:2194–201 doi:10.1093/ndt/gft513 pmid:24463189

   Abstract/FREE Full Text
7. 7.↵
   2. Chauveau D,
   3. Pirson Y,
   4. Verellen-Dumoulin C, et al

   . Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int 1994;45:1140–46 doi:10.1038/ki.1994.151 pmid:8007584

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Xu HW,
   3. Yu SQ,
   4. Mei CL, et al

   . Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease. Stroke 2011;42:204–06 doi:10.1161/STROKEAHA.110.578740 pmid:21164130

   Abstract/FREE Full Text
9. 9.↵
   2. Irazabal MV,
   3. Huston J 3rd.,
   4. Kubly V, et al

   . Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011;6:1274–85 doi:10.2215/CJN.09731110 pmid:21551026

   Abstract/FREE Full Text
10. 10.↵
    2. Jiang T,
    3. Wang P,
    4. Qian Y, et al

    . A follow-up study of autosomal dominant polycystic kidney disease with intracranial aneurysms using 3.0 T three-dimensional time-of-flight magnetic resonance angiography. Eur J Radiol 2013;82:1840–45 doi:10.1016/j.ejrad.2013.01.024 pmid:23466029

    CrossRefPubMed
11. 11.↵
    2. Ars E,
    3. Bernis C,
    4. Fraga G, et al

    ; Spanish Working Group on Inherited Kidney Disease. Spanish guidelines for the management of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2014;29 (suppl 4):iv95–105 doi:10.1093/ndt/gfu186 pmid:25165191

    Abstract/FREE Full Text
12. 12.↵
    2. Tominari S,
    3. Morita A,
    4. Ishibashi T, et al

    ; Unruptured Cerebral Aneurysm Study Japan Investigators. Prediction model for 3-year rupture risk of unruptured cerebral aneurysms in Japanese patients. Ann Neurol 2015;77:1050–59 doi:10.1002/ana.24400 pmid:25753954

    CrossRefPubMed
13. 13.↵
    2. Zhang LT,
    3. Wei FJ,
    4. Zhao Y, et al

    . Intracranial aneurysm risk factor genes: relationship with intracranial aneurysm risk in a Chinese Han population. Genet Mol Res 2015;14:6865–78 doi:10.4238/2015.June.18.30 pmid:26125895

    CrossRefPubMed
14. 14.↵
    2. Xu J,
    3. Ma F,
    4. Yan W, et al

    . Identification of the soluble form of tyrosine kinase receptor Axl as a potential biomarker for intracranial aneurysm rupture. BMC Neurol 2015;15:23 doi:10.1186/s12883-015-0282-8 pmid:25885003

    CrossRefPubMed
15. 15.↵
    2. Ring T,
    3. Spiegelhalter D

    . Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease. Kidney Int 2007;72:1400–02 doi:10.1038/sj.ki.5002488 pmid:17882153

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Niemczyk M,
    3. Niemczyk S,
    4. Bujko M, et al

    . Headache as a manifestation of intracranial aneurysm in autosomal dominant polycystic kidney disease. Neurol Neurochir Pol 2015;49:126–28 doi:10.1016/j.pjnns.2015.02.002 pmid:25890928

    CrossRefPubMed
17. 17.↵
    2. Bajwa ZH,
    3. Sial KA,
    4. Malik AB, et al

    . Pain patterns in patients with polycystic kidney disease. Kidney Int 2004;66:1561–69 doi:10.1111/j.1523-1755.2004.00921.x pmid:15458452

    CrossRefPubMedWeb of Science